drugset / Trial / NCT00130182
A Study in Pediatric Patients With Cystic Fibrosis Lung Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate the safety and effectiveness of two dose strengths of study drug compared to placebo in pediatric patients with cystic fibrosis (CF).
Timeline
- Start
- 2005-08
- Primary completion
- 2006-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | denufosol | Other / unclassified | — | Inhaled |